Latest News in the pharma Industry

Research & Development

First investment for Colorcon Ventures in AI drug discovery leader

13 Aug 2020

Atomwise technology removes the barriers of physical screening that have limited the success of traditional methods for small molecule drug discovery.

Samsung Biologics adds fourth plant due to growing demand

11 Aug 2020

Plant 4 will add 256 KL capacity to its site, which is scheduled to commence manufacturing activities in the second half of 2022.

Moderna inks US deal for 100 million doses of its COVID vaccine

11 Aug 2020

The company is also scaling up its manufacturing capability with its partners — Lonza, Catalent and Rovi — should the vaccine get the green light.

Colorcon opens in Australia to meet growing demand from local pharma industry

4 Aug 2020

Customers in the region will have the opportunity to conduct laboratory-scale compression and coating trials, using automated coating equipment.

Oxford Biomedica signs 3-year CSA for Parkinson’s disease gene therapy program

3 Aug 2020

The company expects to manufacture the clinical-stage gene therapy product in its commercial-scale GMP manufacturing facilities.

Pfizer and BioNTech to supply Japan with 120 million doses of mRNA-based vaccine candidate

3 Aug 2020

The companies are set to manufacture globally up to 100 million doses by the end of 2020 and approximately 1.3 billion doses by the end of 2021.

Construction underway on new Croda North American HQ and Innovation Centre

28 Jul 2020

The facility will support the company'a goal of being climate, land and people positive by 2030.

Vital Signs Solutions receives backing to facilitate mass-scale antibody testing for COVID-19

27 Jul 2020

The company will adapt its digital platform to digitize any COVID-19 antibody rapid test assay and embed this within an app available on smartphones and tablets.

Stevanato Group and Colanar colaborate to study container closure systems

21 Jul 2020

The data generated through the partnership will help biopharma companies to develop robust manufacturing processes and minimize challenges during scale-up and commercialization.

Colorcon launches new enteric coating with pH up to 5.0

20 Jul 2020

Acryl-EZE formulations provide significant time savings and targeted drug delivery.

Humanigen expands partnership with Catalent to manufacture investigational COVID-19 therapeutic candidate